These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


198 related items for PubMed ID: 3578324

  • 1. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
    Scully BE, Jules K, Chin NX, Neu HC.
    Am J Med; 1987 Apr 27; 82(4A):336-8. PubMed ID: 3578324
    [Abstract] [Full Text] [Related]

  • 2. Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora.
    Daikos GL, Kathpalia SB, Sharifi R, Lolans VT, Jackson GG.
    Am J Med; 1987 Apr 27; 82(4A):290-4. PubMed ID: 3555050
    [Abstract] [Full Text] [Related]

  • 3. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC, Cuevas TA, Roccaforte JS, Mellencamp MA, Bittner MJ.
    Am J Med; 1987 Apr 27; 82(4A):295-300. PubMed ID: 3555051
    [Abstract] [Full Text] [Related]

  • 4. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H, Galanakis N.
    Am J Med; 1987 Apr 27; 82(4A):346-51. PubMed ID: 3555059
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oral ciprofloxacin therapy for chronic contiguous osteomyelitis caused by aerobic gram-negative bacilli.
    Gilbert DN, Tice AD, Marsh PK, Craven PC, Preheim LC.
    Am J Med; 1987 Apr 27; 82(4A):254-8. PubMed ID: 3555044
    [Abstract] [Full Text] [Related]

  • 17. [Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study].
    Sollich V, Klöditz E, Schuster R, Handrick W, Brömme S, Rumler W, Patsch R, Kharari H, Spencker FB.
    Kinderarztl Prax; 1993 Aug 27; 61(6):211-4. PubMed ID: 8411847
    [Abstract] [Full Text] [Related]

  • 18. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
    Nix DE, Sands MF, Peloquin CA, Vari AJ, Cumbo TJ, Vance JW, Fracasso JE, Schentag JJ.
    Am J Med; 1987 Apr 27; 82(4A):352-6. PubMed ID: 3555060
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oral ciprofloxacin in refractory gram-negative bacillary infections.
    Bryant RE, Hartstein AI.
    Int J Clin Pharmacol Res; 1987 Apr 27; 7(3):187-94. PubMed ID: 3596862
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.